Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
Clinical trial NCT07235683 · RECRUITING
Trial details
- NCT number
- NCT07235683
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-24
- Primary completion
- 2027-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.